Neoplasm Metastasis
2 competing products in clinical development for Neoplasm Metastasis.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Prexasertib + Cisplatin + Cetuximab + G-CSF + Pemetrexed + Fluorouracil + LY3023414 + Leucovorin | Eli Lilly | Phase 1 | Completed | 29 |
| DS-8201a + Ritonavir + Itraconazole | Daiichi Sankyo | Phase 1 | Completed | 29 |